← All indications
Prehypertension
Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.
Drugs by status
Phase 4 trials (11)
Phase 3 trials (6)
Phase 2 trials (17)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (20)
- Merck
- AOBiome LLC
- Bayer
- GlaxoSmithKline
- HumanN
- LycoRed Ltd.
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- American Heart Association
- Baylor University
- Cedars-Sinai Medical Center
- Cornell University
- McGill University
- University of Iowa
- University of Minnesota
- Maccabi Healthcare Services, Israel
- Veristat, Inc.
- KGK Science Inc.
- Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
- The University of Texas, Dallas
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (22)
- Abbott
- University of London
- Harvard University
- Florida State University
- Mahidol University
- Tulane University
- Thomas Jefferson University
- University of Reading
- Taipei Medical University
- University of Connecticut
- Sprim Consulting
- Illinois Institute of Technology
- Reading University
- Karolinska Institute
- Naturex SA
- The Government Pharmaceutical Organization
- NOW Foods
- Ubonratchathani Cancer Hospital
- Polyphenolics, Inc.
- Government of Thailand
- Endothelix
- Mizkan Holdings Co., Ltd.